Literature DB >> 23460520

Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in mice.

Leonardo A de Almeida1, Gilson C Macedo, Fábio A V Marinho, Marco T R Gomes, Patrícia P Corsetti, Aristóbolo M Silva, Juliana Cassataro, Guillermo H Giambartolomei, Sergio C Oliveira.   

Abstract

Brucella abortus is recognized by several Toll-like receptor (TLR)-associated pathways triggering proinflammatory responses that affect both the nature and intensity of the immune response. Previously, we demonstrated that B. abortus-mediated dendritic cell (DC) maturation and control of infection are dependent on the adaptor molecule MyD88. However, the involvement of all TLRs in response to B. abortus infection is not completely understood. Therefore, we decided to evaluate the requirement for TLR6 in host resistance to B. abortus. Here, we demonstrated that TLR6 is an important component for triggering an innate immune response against B. abortus. An in vitro luciferase assay indicated that TLR6 cooperates with TLR2 to sense Brucella and further activates NF-κB signaling. However, in vivo analysis showed that TLR6, not TLR2, is required for the efficient control of B. abortus infection. Additionally, B. abortus-infected dendritic cells require TLR6 to induce tumor necrosis factor alpha (TNF-α) and interleukin-12 (IL-12). Furthermore, our findings demonstrated that the mitogen-activated protein kinase (MAPK) signaling pathway is impaired in TLR2, TLR6, and TLR2/6 knockout (KO) DCs when infected with B. abortus, which may account for the lower proinflammatory cytokine production observed in TLR6 KO mouse dendritic cells. In summary, the results presented here indicate that TLR6 is required to trigger innate immune responses against B. abortus in vivo and is required for the full activation of DCs to induce robust proinflammatory cytokine production.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460520      PMCID: PMC3647997          DOI: 10.1128/IAI.01356-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages.

Authors:  Paula Barrionuevo; M Victoria Delpino; Lis N Velásquez; Clara García Samartino; Lorena M Coria; Andrés E Ibañez; María Eugenia Rodríguez; Juliana Cassataro; Guillermo H Giambartolomei
Journal:  Microbes Infect       Date:  2010-11-09       Impact factor: 2.700

4.  Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection.

Authors:  Fernanda S Oliveira; Natália B Carvalho; Ana Paula M S Brandão; Marco Túlio R Gomes; Leonardo A de Almeida; Sérgio C Oliveira
Journal:  Infect Immun       Date:  2011-08-15       Impact factor: 3.441

5.  The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.

Authors:  Cyntia G M C Trant; Thais L S Lacerda; Natalia B Carvalho; Vasco Azevedo; Gracia M S Rosinha; Suzana P Salcedo; Jean-Pierre Gorvel; Sergio C Oliveira
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

6.  Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus.

Authors:  Romina Scian; Paula Barrionuevo; Guillermo H Giambartolomei; Carlos A Fossati; Pablo C Baldi; M Victoria Delpino
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

Review 7.  The role of innate immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond.

Authors:  Sergio Costa Oliveira; Fernanda Souza de Oliveira; Gilson Costa Macedo; Leonardo Augusto de Almeida; Natalia Barbosa Carvalho
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

8.  TLR2-, TLR4- and Myd88-independent acquired humoral and cellular immunity against Salmonella enterica serovar Typhimurium.

Authors:  Sabine A Seibert; Peggy Mex; Anne Köhler; Stefan H E Kaufmann; Hans-Willi Mittrücker
Journal:  Immunol Lett       Date:  2009-11-04       Impact factor: 3.685

9.  Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion.

Authors:  M S Shey; A K Randhawa; M Bowmaker; E Smith; T J Scriba; M de Kock; H Mahomed; G Hussey; T R Hawn; W A Hanekom
Journal:  Genes Immun       Date:  2010-05-06       Impact factor: 2.676

10.  Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice.

Authors:  Ana Paula M S Brandão; Fernanda S Oliveira; Natalia B Carvalho; Leda Q Vieira; Vasco Azevedo; Gilson C Macedo; Sergio C Oliveira
Journal:  Clin Dev Immunol       Date:  2011-12-11
View more
  22 in total

Review 1.  Clinical view on the importance of dendritic cells in asthma.

Authors:  Rohit Gaurav; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2013-10       Impact factor: 4.473

2.  Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation.

Authors:  Carolyn A Lacey; William J Mitchell; Charles R Brown; Jerod A Skyberg
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

3.  Functional Impairment of Murine Dendritic Cell Subsets following Infection with Infective Larval Stage 3 of Brugia malayi.

Authors:  Aditi Sharma; Pankaj Sharma; Achchhe Lal Vishwakarma; Mrigank Srivastava
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Immunoproteasome Subunits Are Required for CD8+ T Cell Function and Host Resistance to Brucella abortus Infection in Mice.

Authors:  Gabriela Guimarães; Marco Túlio R Gomes; Priscila C Campos; Fabio V Marinho; Natan R G de Assis; Tatiana N Silveira; Sergio C Oliveira
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

5.  Comparative RNA-sequencing analysis of ER-based HSP90 functions and signal pathways in Tribolium castaneum.

Authors:  Wenfeng Xiong; Mengfan Zhai; Xiaojuan Yu; Luting Wei; Jinjuan Mao; Juanjuan Liu; Jia Xie; Bin Li
Journal:  Cell Stress Chaperones       Date:  2017-07-05       Impact factor: 3.667

6.  NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus.

Authors:  Tatiana N Silveira; Marco Túlio R Gomes; Luciana S Oliveira; Priscila C Campos; Gabriela G Machado; Sergio C Oliveira
Journal:  Eur J Immunol       Date:  2016-12-05       Impact factor: 5.532

7.  The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.

Authors:  Jun Ho Jeon; Hae-Ri Lee; Min-Hee Cho; Ok-Kyu Park; Jungchan Park; Gi-eun Rhie
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

8.  TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus.

Authors:  Marco Túlio Gomes; Priscila Carneiro Campos; Guilherme de Sousa Pereira; Daniella Castanheira Bartholomeu; Gary Splitter; Sergio Costa Oliveira
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

9.  Testosterone persistently dysregulates hepatic expression of Tlr6 and Tlr8 induced by Plasmodium chabaudi malaria.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem S Abdel-Baki; Marcos J Araúzo-Bravo; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2014-07-24       Impact factor: 2.289

10.  Toll-like receptor alterations in myelodysplastic syndrome.

Authors:  Y Wei; S Dimicoli; C Bueso-Ramos; R Chen; H Yang; D Neuberg; S Pierce; Y Jia; H Zheng; H Wang; X Wang; M Nguyen; S A Wang; B Ebert; R Bejar; R Levine; O Abdel-Wahab; M Kleppe; I Ganan-Gomez; H Kantarjian; G Garcia-Manero
Journal:  Leukemia       Date:  2013-06-14       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.